Objectives: Use of variable fields of view (FOV) to limit CBCT image volumes to specific regions of interest (ROI) is a potential means of reducing risk from CBCT imaging. The effectiveness of this approach was evaluated using the NewTom VGi unit by measuring effective dose for a variety of FOVs and ROIs.
Methods: Dosimetry of 6x6cm to 15x15cm FOVs at various resolutions were evaluated using Optical Stimulated Luminescent dosimeters (Landauer NanoDot) placed at 24 locations within and on a RANDO phantom (Ludlow et al 2008). Effective dose was derived using the 2007 ICRP calculation. Exposure settings were optimized for image quality and patient size by the automatic exposure control function of the unit. Data were evaluated with ANOVA.
Results: Significant increases in dose were related to increasing FOV (p=0.015). Significant increases in dose were also related to increasing resolution (p=0.048).
Table: Effective Dose by FOV size and resolution
FOV size and resolution
| 15x15cm standard resolution
| 12x15cm standard resolution
| 8x12cm standard resolution
| 8x8cm standard resolution
| 8x12cm high resolution
| 8x8cm high resolution
|
Effective Dose in µSv
| 99
| 86
| 69
| 51
| 235
| 172
|
Table: Effective Dose by location and jaw for 6x6cm high resolution FOV
location
| posterior
| anterior
| posterior
| anterior
|
Jaw
| mandible
| mandible
| maxilla
| maxilla
|
Effective Dose in µSv
| 160
| 117
| 109
| 109
|
Conclusions: Use of variable FOVs and standard resolution reduced dose in every instance in comparison with larger FOVs of the same region or higher resolution.
This research was supported by ImageWorks, Elmsford, NY and NIDCR grant 1R21DE022160-01
Keywords: Radiology and dosimetry